We are working on the development of perovskite solar cells to contribute to Japan’s decarbonization.
Taking advantage of their lightweight and flexibility, we aim to establish installation methods for them on building walls where conventional silicon solar cells cannot be installed, as well as gymnasiums and plant roofs that have load restrictions.
We are actively working on verification with a view to commercialization in 2025.

We developed and commercialized revolutionary large, thin lithium-ion batteries that achieve large capacity, long life, high safety, and small footprints. Products manufactured at our domestic plants are increasingly used in homes, and save money when paired with solar power. We provide peace of mind for our customers’ lifestyles in the event of a disaster. In future, we shall move ahead with expansion to public facilities and so on, contributing to improved renewable energy rates and the creation of resilient communities.

We developed technology that uses microorganisms to convert gas generated by waste incinerators into ethanol. Moving ahead with our collaborations with government and other companies, we started verification test at our demonstration plant in Kuji, Iwate Prefecture in FY 2022. The first commercial-scale BR plant is targeted to begin production in FY2028. Please also take a look at our UNISON brand, which shares a world-view of a recycling society that does not depend on fossil fuels.

Japan’s first plasma therapy device for animals, “Pidi,” is effective at reducing gum inflammation and bad breath in dogs. The active species using nitrogen gas allows treatment that is gentle and with less irritation on animals. The plasma technology we have cultivated　over 20 years in semiconductors and displays has made it possible to make the device lightweight and compact.

We are developing thechnology for the separation from gas, collection, and reuse of CO₂ eitted when producing steel and are working on international joint research and development with ArcelorMittal, S.A., a world-leading steel and mining company, on carbon recycling for use in steel processing.

iPS cells are used in cutting-edge life sciences such as regenerative medicine. We are working on developing chemically synthesized scaffolds to easily and stably cultivation of iPS cells. By applying this scaffold to the surfaces of various culture vessels, we will solve the issues faced by regenerative medicine, such as the automation of cell production and mass culturing. In collaboration with researchers and other companies, we will contribute to the creation of future medicine.